【结 构 式】 |
【分子编号】26079 【品名】Isonicotinohydrazide 【CA登记号】54-85-3 |
【 分 子 式 】C6H7N3O 【 分 子 量 】137.1412 【元素组成】C 52.55% H 5.14% N 30.64% O 11.67% |
合成路线1
该中间体在本合成路线中的序号:(B)A mixture of freshly distilled pyridine (A) and 1-chloro-2,4-dinitrobenzene (I) in dry acetone is allowed to reflux for 15 h. Removal of the solvent in vacuo affords a residue which is washed with ether, recrystallized in absolute ethanol and characterized as N-(2,4-dinitrophenyl)pyridinium chloride (II). To an ice-cooled solution of compound (II) in methanol, a suspension of isonicotinic acid hydrazide in methanol in five aliquots is added with stirring. Triethylamine is then added and the reaction is allowed to stand at room temperature overnight. The solid which precipitates is purified and characterized as compound (III). A suspension of compound (III) in dioxane:water (4:1 v/v) is heated under reflux for 12 h to afford a clear solution. Separation and purification of the products gives a yellowish crystalline solid of N-(4-pyridylcarbonylimino)pyridiniumylide (IV) and 2,4-dinitroaniline (V). A solution of compound (IV) in 95% ethanol is added dropwise to a solution of sodium borohydride in 95% ethanol pre-cooled to 0 C. After stirring for 4 h at 0 C, the reaction mixture is poured onto crushed ice and allowed to come to room temperature. Extraction with chloroform, drying and purification yields N-(4-pyridylcarbonylamino)-1,2,3,6-tetrahydropyridine.
【1】 Knaus, E.E.; Redda, K.; J Heterocycl Chem 1976, 13, 1237. |
【2】 Knaus, E.E.; Corleto, L.A.; Redda, K. (Canadian Patents & Development Ltd.); N-(Carbonylamino)-tetrahydropyridyl derivatives. CA 1094073; US 4338445 . |
【3】 Knaus, E.E.; Brush, J.S.; Martí, A.; Redda, K.; PATP. Drugs Fut 1985, 10, 6, 465. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(B) | 26079 | Isonicotinohydrazide | 54-85-3 | C6H7N3O | 详情 | 详情 |
(A) | 29669 | Pyridine | 110-86-1 | C5H5N | 详情 | 详情 |
(I) | 10378 | 1-Chloro-2,4-dinitrobenzene | 97-00-7 | C6H3ClN2O4 | 详情 | 详情 |
(II) | 29670 | 1-(2,4-dinitrophenyl)pyridinium chloride | C11H8ClN3O4 | 详情 | 详情 | |
(III) | 29671 | 1-(2,4-dinitrophenyl)-2-(2-isonicotinoylhydrazino)pyridinium chloride | C17H13ClN6O5 | 详情 | 详情 | |
(IV) | 29672 | N-(1-Pyridinio)-pyridine-4-carboxamidate | C11H9N3O | 详情 | 详情 | |
(V) | 29673 | 2,4-dinitroaniline; 2,4-dinitrophenylamine | 97-02-9 | C6H5N3O4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)The condensation of 2,4-bis(1-pyrrolidinyl)-6-(1-piperazinyl)pyrimidine (I) with 3-(bromomethyl)-5-chlorobenzonitrile (II) gives the disubstituted piperazine derivative (III). The partial hydrolysis of the CN group of (III) with methanol/HCl yiedls the iminoether (IV), which is condensed with 4-pyridylcarbonylhydrazide (V) to afford the amidrazone (VI). Finally, this compound is cyclized by heating.
【1】 van der Goot, H.; et al.; New antioxidants with strong free radical scavenging and xanthine oxidase inhibiting activity. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.243. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26075 | 4-(1-piperazinyl)-2,6-di(1-pyrrolidinyl)pyrimidine | C16H26N6 | 详情 | 详情 | |
(II) | 26076 | 3-(bromomethyl)-5-chlorobenzonitrile | C8H5BrClN | 详情 | 详情 | |
(III) | 26077 | 3-chloro-5-([4-[2,6-di(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]methyl)benzonitrile | C24H30ClN7 | 详情 | 详情 | |
(IV) | 26078 | methyl 3-chloro-5-([4-[2,6-di(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]methyl)benzenecarboximidoate | C25H34ClN7O | 详情 | 详情 | |
(V) | 26079 | Isonicotinohydrazide | 54-85-3 | C6H7N3O | 详情 | 详情 |
(VI) | 26080 | N'-[[3-chloro-5-([4-[2,6-di(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]methyl)phenyl](imino)methyl]isonicotinohydrazide | C30H37ClN10O | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)Isoniazid (I) was treated with carbon disulfide and KOH to give potassium 4-pyridyl dithiocarbazinate (II). Cyclization of (II) in the presence of hydrazine produced the amino triazole (III). This was condensed with 5-bromoisatin (IV), yielding the imino adduct (V). Finally, Mannich reaction of (V) with piperidine (VI) and formaldehyde furnished the title compound.
【1】 de Clercq, E.; Nath, G.; Pandeya, S.N.; Sriram, D.; Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole. Arzneim-Forsch Drug Res 2000, 50, 1, 55. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26079 | Isonicotinohydrazide | 54-85-3 | C6H7N3O | 详情 | 详情 |
(II) | 43763 | potassium 2-isonicotinoyl-1-hydrazinecarbodithioate | C7H6KN3OS2 | 详情 | 详情 | |
(III) | 43764 | 4-amino-5-(4-pyridinyl)-4H-1,2,4-triazole-3-thiol; 4-amino-5-(4-pyridinyl)-4H-1,2,4-triazol-3-ylhydrosulfide | C7H7N5S | 详情 | 详情 | |
(IV) | 42952 | 6,8,11-trihydroxy-7H-benzo[e]perimidin-7-one | C15H8N2O4 | 详情 | 详情 | |
(V) | 43765 | 5-bromo-3-[[3-(4-pyridinyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]imino]-1H-indol-2-one | C15H9BrN6OS | 详情 | 详情 | |
(VI) | 10158 | Piperidine | 110-89-4 | C5H11N | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(II)The known (methylmercapto)benzodiazepine (I) was condensed with isonicotinic hydrazide (II) in refluxing EtOH to give the intermediate hydrazinobenzodiazepine (III), which under the reaction conditions cyclized to the target triazolobenzodiazepine.
【1】 Vega, S.; Madronero, R.; Synthesis of triazolo[4,3-d]-, tetrazolo[1,5-a]- and quinazolino[3,2-d] [1,4]benzodiazepines. J Heterocycl Chem 1978, 15, 7, 1127. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50129 | methyl 1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-5-yl sulfide; 1-methyl-5-(methylsulfanyl)-2,3-dihydro-1H-1,4-benzodiazepine | C11H14N2S | 详情 | 详情 | |
(II) | 26079 | Isonicotinohydrazide | 54-85-3 | C6H7N3O | 详情 | 详情 |
(III) | 50130 | N'-(1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)isonicotinohydrazide | C16H17N5O | 详情 | 详情 |